# Parabilis Medicines, Inc. (PBLS): MoatMap facts

As of 21 Nov 2026. Research data, not investment advice.

As of 21 Nov 2026, the MoatMap Score for Parabilis Medicines, Inc. (PBLS) is 4/100, ranked against 25,000+ stocks in 38 markets (Quality 18, Value 24, Momentum 27, each scored against its sector).

- MoatMap Score: 4/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 18, Value 24, Momentum 27: each a 0-100 percentile within Healthcare.
- Position: #25,417 overall, #2,525 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 27.44 USD on 20 Nov 2026.
- Insider filings, last 180 days: directors bought USD 431.4M; 5%+ holders bought USD 10.0M.

Source: https://moatmap.ai/stock/PBLS
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
